INSIGHTS ON DRUG DEVELOPMENT

• Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing

  See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

• Optimize Your mAb Capture And Polishing With The Latest Resins And Tips

  Discover the latest innovations in monoclonal antibody purification and explore resin selection strategies to optimize product quality and improve process efficiency.

• New Approaches To Tailored Release Profiles

  Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

• Organ-Chips Outperform Animal Models And Spheroids

  Examine how 780 human Liver-Chips were assessed for their ability to predict drug-induced liver injury from small molecules.

• How Solid-State Science Solves Your Toughest API Challenges

  6/3/2026

  Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.

• A Study To Assess Organoid Size And Cell Count From 3D Image Analysis

  4/4/2025

  Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.

• Together, Let's Sail Toward Success

  7/23/2025

  Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

• Bioprocess Training And Education

  3/17/2026

  Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.

• Screening For Amorphous Drug Substance

  5/6/2026

  Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.